Walleye Capital LLC Oyster Point Pharma, Inc. Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.41 - $8.38 $89,002 - $169,125	20,182 New	20,182 $113,000
Q1 2022 May 16, 2022	SELL	$8.58 - $17.65 $126,700 - $260,637	-14,767 Closed	0 $0
Q4 2021 Mar 03, 2022	SELL	$10.17 - $18.96 $111,595 - $208,048	-10,973 Reduced 42.63%	14,767 $269,000
Q3 2021 Nov 15, 2021	BUY	$11.67 - $18.07 $300,385 - $465,121	25,740 New	25,740 $305,000
Q4 2020 Feb 16, 2021	SELL	$18.13 - $25.18 $206,863 - $287,303	-11,410 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$17.83 - $29.12 $203,440 - $332,259	11,410 New	11,410 $241,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.